氣喘治療市場按藥物類別、給藥途徑、通路和地區分類

Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年01月30日 | 出版商:

Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，氣喘藥物市值將達到 204.4 億美元，到 2033 年將達到 233 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 1.9%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	204.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	1.90%	2033 年的預測值：	233億美元

氣喘是一種慢性發炎性疾病，會導致肺部氣道發炎和狹窄。其特徵是多種症狀，氣喘氣道內壁腫脹和發炎、咳嗽、呼吸急促和胸悶。氣喘分為多種類型，包括過敏性氣喘、非過敏性氣喘、成人起病型氣喘、運動性氣喘（在運動過程中發生）、夜間氣喘和職業性氣喘。夜間氣喘也稱為夜間氣喘。由於它是一種非常嚴重的氣喘類型，因此正確的診斷和治療至關重要。

市場動態

主要企業不斷推出新型霧化器產品，預計將推動全球氣喘藥物市場成長。例如，2018年10月，皇家飛利浦公司宣佈在北美推出其新型網狀霧化器「InnoSpire Go」。本產品用於治療包括氣喘在內的呼吸系統疾病。它是一款攜帶式手持霧化器系統，可實現快速治療，僅需四分鐘即可完成藥物輸送。 InnoSpire Go 適用於成人和兒童。

然而，產品召回是限制氣喘藥物市場成長的主要因素，預計會阻礙市場成長。例如，2018年8月，美國食品藥物管理局（FDA）發布了針對Camber Pharmaceuticals公司生產的Montelukast sodium錠的召回警報。召回原因是Montelukast sodium片的瓶子裡裝錯了藥物（氯沙坦鉀片）。

本次調查的主要特點

本報告以 2025 年為基準年，對全球氣喘藥物市場規模（十億美元）和預測期（2026-2033 年）的複合年成長率（%）進行了詳細分析。
該報告重點介紹了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數介紹了全球氣喘藥物市場主要企業的概況：公司概況、財務表現、產品系列、地理擴張、分銷策略、主要發展和策略。
本報告的研究結果將使企業負責人和經營團隊能夠就未來的產品發布、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球氣喘藥物市場報告將為行業內的各種相關人員提供有價值的資訊，包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 我們。
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
非洲
- 北非
- 中非
- 南非
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家

第8章競爭情勢

熱圖分析
公司簡介
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceutical Ltd.
- Merck &Co. Inc.
- Roche Diagnostics

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI2698

Asthma Therapeutics Market is estimated to be valued at USD 20.44 Bn in 2026 and is expected to reach USD 23.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 20.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.90%	2033 Value Projection:	USD 23.30 Bn

Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.

Market Dynamics

Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.

However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).

Key features of the study

This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global asthma therapeutics market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
- Corticosteroids
- Beta2-Agonists (Long-Acting and Short-Acting)
- Leukotriene Inhibitors
- Long-Acting Muscarinic Antagonists (LAMA)
- Interleukin Antagonists
- Anti-Immunoglobulin E (IgE) Agents
- Combination Products
- Others
Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
- Oral, Inhalation
- Injection
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH,
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Roche Diagnostics

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Epidemiology
Product Recalls
Government Initiatives
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Corticosteroids
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Beta2-Agonists (Long-Acting and Short-Acting)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Leukotriene Inhibitors
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Long-Acting Muscarinic Antagonists (LAMA)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Interleukin Antagonists
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-Immunoglobulin E (IgE) Agents
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Combination Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)

Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Inhalation
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Injection
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - US.
  - Canada
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - UK.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- GlaxoSmithKline Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Philips Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi- Aventis SA
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CareFusion Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sunovion Pharmaceutical Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co. Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Roche Diagnostics
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views